Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Reward | 82 | 2024 | 980 | 11.840 |
Why?
|
Depressive Disorder, Major | 75 | 2024 | 4810 | 10.980 |
Why?
|
Gyrus Cinguli | 30 | 2024 | 1118 | 5.330 |
Why?
|
Evoked Potentials | 25 | 2020 | 1050 | 3.970 |
Why?
|
Stress, Psychological | 24 | 2024 | 4527 | 3.650 |
Why?
|
Prefrontal Cortex | 32 | 2023 | 2224 | 3.340 |
Why?
|
Sertraline | 5 | 2020 | 210 | 2.940 |
Why?
|
Reaction Time | 38 | 2021 | 2085 | 2.670 |
Why?
|
Electroencephalography | 40 | 2022 | 6282 | 2.540 |
Why?
|
Depression | 36 | 2024 | 8228 | 2.490 |
Why?
|
Affect | 22 | 2022 | 1494 | 2.380 |
Why?
|
Emotions | 22 | 2022 | 2758 | 2.250 |
Why?
|
Feedback, Psychological | 7 | 2019 | 97 | 2.230 |
Why?
|
Brain | 64 | 2024 | 27159 | 2.200 |
Why?
|
Corpus Striatum | 13 | 2024 | 1218 | 2.180 |
Why?
|
Depressive Disorder | 18 | 2021 | 3715 | 2.120 |
Why?
|
Executive Function | 8 | 2021 | 1396 | 2.100 |
Why?
|
gamma-Aminobutyric Acid | 8 | 2024 | 1139 | 2.020 |
Why?
|
Neural Pathways | 17 | 2024 | 3079 | 1.890 |
Why?
|
Magnetic Resonance Imaging | 76 | 2024 | 36567 | 1.810 |
Why?
|
Theta Rhythm | 7 | 2018 | 220 | 1.810 |
Why?
|
Brain Mapping | 45 | 2024 | 6596 | 1.780 |
Why?
|
Learning | 15 | 2024 | 1754 | 1.760 |
Why?
|
Dopamine | 8 | 2024 | 1581 | 1.490 |
Why?
|
Hydrocortisone | 7 | 2024 | 1838 | 1.450 |
Why?
|
Nicotine | 9 | 2021 | 680 | 1.420 |
Why?
|
Rodentia | 2 | 2023 | 262 | 1.400 |
Why?
|
Cognition | 21 | 2023 | 7057 | 1.370 |
Why?
|
Psychopathology | 4 | 2023 | 434 | 1.360 |
Why?
|
Nerve Net | 14 | 2024 | 2307 | 1.330 |
Why?
|
Rest | 9 | 2019 | 940 | 1.330 |
Why?
|
Facial Expression | 7 | 2015 | 515 | 1.330 |
Why?
|
Frontal Lobe | 7 | 2016 | 1408 | 1.250 |
Why?
|
Antidepressive Agents | 11 | 2021 | 2903 | 1.230 |
Why?
|
Attention | 13 | 2019 | 2413 | 1.220 |
Why?
|
Impulsive Behavior | 3 | 2024 | 345 | 1.180 |
Why?
|
Motivation | 14 | 2024 | 2020 | 1.160 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2019 | 410 | 1.160 |
Why?
|
Young Adult | 70 | 2024 | 59939 | 1.130 |
Why?
|
Nicotinic Agonists | 3 | 2018 | 265 | 1.080 |
Why?
|
Psychomotor Performance | 12 | 2019 | 1885 | 1.080 |
Why?
|
Neuropsychological Tests | 18 | 2021 | 7119 | 1.070 |
Why?
|
Adult | 135 | 2024 | 223307 | 1.040 |
Why?
|
Mental Recall | 5 | 2020 | 1218 | 1.020 |
Why?
|
Caudate Nucleus | 3 | 2020 | 388 | 0.960 |
Why?
|
Female | 164 | 2024 | 396520 | 0.950 |
Why?
|
Humans | 224 | 2024 | 766766 | 0.940 |
Why?
|
Cerebral Cortex | 15 | 2024 | 5753 | 0.930 |
Why?
|
Cues | 13 | 2020 | 877 | 0.920 |
Why?
|
Punishment | 4 | 2023 | 95 | 0.910 |
Why?
|
Cognition Disorders | 7 | 2022 | 3967 | 0.910 |
Why?
|
Association Learning | 4 | 2018 | 219 | 0.900 |
Why?
|
Adolescent | 66 | 2024 | 88904 | 0.860 |
Why?
|
Individuality | 4 | 2023 | 303 | 0.850 |
Why?
|
Stress Disorders, Post-Traumatic | 17 | 2024 | 4628 | 0.850 |
Why?
|
Anxiety | 19 | 2023 | 4670 | 0.830 |
Why?
|
Receptors, Opioid, kappa | 1 | 2024 | 133 | 0.820 |
Why?
|
Receptors, Opioid, mu | 1 | 2024 | 167 | 0.820 |
Why?
|
Amygdala | 10 | 2023 | 1375 | 0.820 |
Why?
|
Male | 135 | 2024 | 364142 | 0.820 |
Why?
|
Bipolar Disorder | 8 | 2024 | 5130 | 0.790 |
Why?
|
Tobacco Use Disorder | 9 | 2021 | 708 | 0.760 |
Why?
|
Hippocampus | 7 | 2021 | 3776 | 0.760 |
Why?
|
Internal Capsule | 2 | 2023 | 137 | 0.750 |
Why?
|
Psychiatric Status Rating Scales | 20 | 2021 | 6020 | 0.740 |
Why?
|
Functional Laterality | 10 | 2013 | 2243 | 0.740 |
Why?
|
Nucleus Accumbens | 4 | 2023 | 360 | 0.740 |
Why?
|
Fear | 5 | 2023 | 1496 | 0.720 |
Why?
|
Affective Symptoms | 3 | 2010 | 418 | 0.710 |
Why?
|
Mental Disorders | 6 | 2023 | 6869 | 0.710 |
Why?
|
Placebo Effect | 1 | 2024 | 515 | 0.700 |
Why?
|
Scalp | 2 | 2022 | 390 | 0.680 |
Why?
|
Magnetic Resonance Spectroscopy | 7 | 2024 | 3681 | 0.660 |
Why?
|
Schizophrenic Psychology | 4 | 2019 | 1647 | 0.660 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 2 | 2011 | 326 | 0.630 |
Why?
|
Basal Ganglia | 3 | 2010 | 549 | 0.610 |
Why?
|
Sex Offenses | 1 | 2022 | 355 | 0.600 |
Why?
|
Mood Disorders | 4 | 2021 | 1127 | 0.600 |
Why?
|
Neostriatum | 1 | 2019 | 231 | 0.600 |
Why?
|
Habenula | 1 | 2018 | 40 | 0.590 |
Why?
|
Behavior | 3 | 2012 | 538 | 0.590 |
Why?
|
Positron-Emission Tomography | 10 | 2024 | 6550 | 0.580 |
Why?
|
Benzothiazoles | 2 | 2009 | 244 | 0.570 |
Why?
|
Anticipation, Psychological | 2 | 2018 | 90 | 0.570 |
Why?
|
Dopamine Antagonists | 3 | 2020 | 279 | 0.570 |
Why?
|
Evoked Potentials, Visual | 3 | 2021 | 417 | 0.560 |
Why?
|
Delta Rhythm | 2 | 2016 | 81 | 0.560 |
Why?
|
Endophenotypes | 2 | 2018 | 258 | 0.560 |
Why?
|
Sulpiride | 1 | 2016 | 13 | 0.560 |
Why?
|
Neurosciences | 2 | 2021 | 384 | 0.550 |
Why?
|
Receptors, Dopamine D3 | 3 | 2022 | 106 | 0.550 |
Why?
|
Citalopram | 4 | 2017 | 402 | 0.550 |
Why?
|
Ventral Tegmental Area | 1 | 2018 | 136 | 0.540 |
Why?
|
Adult Survivors of Child Abuse | 3 | 2023 | 301 | 0.530 |
Why?
|
Probability Learning | 4 | 2021 | 23 | 0.520 |
Why?
|
Double-Blind Method | 13 | 2024 | 12430 | 0.500 |
Why?
|
Glutamic Acid | 3 | 2019 | 1181 | 0.500 |
Why?
|
Autopsy | 1 | 2019 | 1011 | 0.500 |
Why?
|
Pleasure | 4 | 2019 | 41 | 0.500 |
Why?
|
Diffusion Tensor Imaging | 4 | 2023 | 2418 | 0.490 |
Why?
|
Narcotic Antagonists | 1 | 2020 | 591 | 0.490 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 944 | 0.480 |
Why?
|
Adaptation, Psychological | 3 | 2016 | 2662 | 0.480 |
Why?
|
Reinforcement Schedule | 7 | 2019 | 123 | 0.480 |
Why?
|
Anxiety Disorders | 7 | 2022 | 2744 | 0.480 |
Why?
|
Synaptic Transmission | 2 | 2020 | 1175 | 0.460 |
Why?
|
Parietal Lobe | 2 | 2018 | 859 | 0.450 |
Why?
|
Social Behavior | 4 | 2019 | 1147 | 0.440 |
Why?
|
Conditioning, Operant | 4 | 2019 | 306 | 0.440 |
Why?
|
Feedback | 2 | 2008 | 797 | 0.440 |
Why?
|
Pattern Recognition, Visual | 5 | 2008 | 820 | 0.430 |
Why?
|
Photic Stimulation | 9 | 2021 | 1989 | 0.430 |
Why?
|
Analysis of Variance | 13 | 2014 | 6214 | 0.430 |
Why?
|
Nonlinear Dynamics | 1 | 2015 | 490 | 0.420 |
Why?
|
Middle Aged | 58 | 2024 | 223257 | 0.420 |
Why?
|
Corpus Callosum | 1 | 2018 | 751 | 0.420 |
Why?
|
Child Abuse | 2 | 2023 | 1090 | 0.420 |
Why?
|
Arousal | 4 | 2022 | 1174 | 0.420 |
Why?
|
Adolescent Development | 1 | 2016 | 273 | 0.420 |
Why?
|
Anger | 3 | 2015 | 402 | 0.410 |
Why?
|
Schizophrenia | 8 | 2019 | 6976 | 0.410 |
Why?
|
Nortriptyline | 2 | 2004 | 79 | 0.410 |
Why?
|
Cluster Analysis | 1 | 2019 | 2717 | 0.410 |
Why?
|
Data Interpretation, Statistical | 4 | 2019 | 2693 | 0.410 |
Why?
|
Semantics | 4 | 2008 | 609 | 0.400 |
Why?
|
Tomography | 6 | 2015 | 443 | 0.400 |
Why?
|
Extinction, Psychological | 2 | 2021 | 367 | 0.400 |
Why?
|
Memory Disorders | 2 | 2018 | 1193 | 0.400 |
Why?
|
Organ Size | 5 | 2017 | 2261 | 0.390 |
Why?
|
Task Performance and Analysis | 4 | 2008 | 771 | 0.390 |
Why?
|
Anorexia Nervosa | 1 | 2020 | 1328 | 0.370 |
Why?
|
Biology | 1 | 2023 | 292 | 0.370 |
Why?
|
Memory | 4 | 2018 | 2192 | 0.370 |
Why?
|
Image Processing, Computer-Assisted | 13 | 2023 | 8926 | 0.370 |
Why?
|
Self Concept | 2 | 2015 | 1040 | 0.370 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 1 | 2011 | 88 | 0.370 |
Why?
|
Happiness | 2 | 2015 | 170 | 0.370 |
Why?
|
Case-Control Studies | 13 | 2024 | 22248 | 0.370 |
Why?
|
Antidepressive Agents, Tricyclic | 2 | 2004 | 427 | 0.350 |
Why?
|
Color Perception | 2 | 2010 | 211 | 0.350 |
Why?
|
Receptors, Dopamine D2 | 3 | 2021 | 471 | 0.350 |
Why?
|
Decision Making | 6 | 2022 | 3951 | 0.350 |
Why?
|
Child Abuse, Sexual | 1 | 2013 | 398 | 0.350 |
Why?
|
Rats | 6 | 2023 | 23717 | 0.340 |
Why?
|
Choice Behavior | 3 | 2019 | 846 | 0.340 |
Why?
|
Dominance, Cerebral | 5 | 2008 | 616 | 0.340 |
Why?
|
Adolescent Behavior | 2 | 2019 | 1184 | 0.340 |
Why?
|
Brain Waves | 1 | 2014 | 416 | 0.340 |
Why?
|
Dissociative Disorders | 2 | 2022 | 234 | 0.340 |
Why?
|
Phenotype | 8 | 2022 | 16724 | 0.330 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2010 | 57 | 0.330 |
Why?
|
Putamen | 1 | 2010 | 288 | 0.320 |
Why?
|
Face | 3 | 2000 | 1029 | 0.320 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2010 | 167 | 0.320 |
Why?
|
Conditioning, Classical | 2 | 2020 | 368 | 0.320 |
Why?
|
Mental Processes | 2 | 2020 | 242 | 0.310 |
Why?
|
Dopamine Agonists | 2 | 2020 | 346 | 0.310 |
Why?
|
Bupropion | 2 | 2020 | 303 | 0.300 |
Why?
|
Signal Processing, Computer-Assisted | 4 | 2009 | 1457 | 0.300 |
Why?
|
Circadian Rhythm | 2 | 2018 | 2593 | 0.300 |
Why?
|
Cross-Over Studies | 5 | 2022 | 2108 | 0.300 |
Why?
|
Consummatory Behavior | 1 | 2007 | 5 | 0.300 |
Why?
|
Treatment Outcome | 16 | 2024 | 65273 | 0.290 |
Why?
|
Life Change Events | 3 | 2021 | 956 | 0.290 |
Why?
|
Computational Biology | 1 | 2019 | 3564 | 0.280 |
Why?
|
Regression Analysis | 6 | 2019 | 6329 | 0.280 |
Why?
|
Space Perception | 2 | 2008 | 468 | 0.280 |
Why?
|
Thinking | 2 | 2010 | 320 | 0.280 |
Why?
|
Signal Detection, Psychological | 6 | 2019 | 83 | 0.280 |
Why?
|
Smoking | 11 | 2021 | 9077 | 0.270 |
Why?
|
Twins | 1 | 2008 | 341 | 0.270 |
Why?
|
Sex Characteristics | 3 | 2024 | 2645 | 0.270 |
Why?
|
Avoidance Learning | 2 | 2019 | 248 | 0.260 |
Why?
|
Models, Psychological | 5 | 2015 | 823 | 0.260 |
Why?
|
Orientation | 1 | 2008 | 314 | 0.260 |
Why?
|
Phobic Disorders | 1 | 2008 | 440 | 0.260 |
Why?
|
Animals | 20 | 2024 | 168930 | 0.260 |
Why?
|
Genotype | 5 | 2011 | 13036 | 0.250 |
Why?
|
Drug Discovery | 1 | 2023 | 1065 | 0.250 |
Why?
|
Raclopride | 2 | 2022 | 98 | 0.240 |
Why?
|
Parapsychology | 2 | 2001 | 4 | 0.240 |
Why?
|
Probability | 5 | 2013 | 2476 | 0.230 |
Why?
|
Severity of Illness Index | 7 | 2017 | 15908 | 0.220 |
Why?
|
Biomedical Research | 1 | 2019 | 3459 | 0.220 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3837 | 0.220 |
Why?
|
Bayes Theorem | 3 | 2020 | 2354 | 0.220 |
Why?
|
Recurrence | 4 | 2019 | 8507 | 0.220 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 4 | 2020 | 1988 | 0.220 |
Why?
|
Opioid Peptides | 1 | 2023 | 37 | 0.220 |
Why?
|
Child | 11 | 2023 | 80668 | 0.220 |
Why?
|
Awareness | 1 | 2008 | 653 | 0.220 |
Why?
|
Personality Inventory | 5 | 2008 | 1019 | 0.210 |
Why?
|
Attitude | 1 | 2008 | 768 | 0.210 |
Why?
|
Receptors, Opioid | 1 | 2023 | 145 | 0.210 |
Why?
|
Receptors, CXCR | 1 | 2023 | 52 | 0.210 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 26310 | 0.200 |
Why?
|
Leukotriene B4 | 1 | 2023 | 281 | 0.190 |
Why?
|
Accidents, Traffic | 3 | 2021 | 818 | 0.190 |
Why?
|
Psychometrics | 5 | 2021 | 3060 | 0.190 |
Why?
|
Mysticism | 1 | 2001 | 3 | 0.190 |
Why?
|
Anisotropy | 3 | 2023 | 1285 | 0.190 |
Why?
|
KCNQ3 Potassium Channel | 1 | 2021 | 10 | 0.190 |
Why?
|
Adaptation, Physiological | 1 | 2008 | 1313 | 0.190 |
Why?
|
Oxygen | 4 | 2015 | 4251 | 0.190 |
Why?
|
KCNQ2 Potassium Channel | 1 | 2021 | 19 | 0.190 |
Why?
|
Membrane Transport Modulators | 1 | 2021 | 24 | 0.180 |
Why?
|
Dreams | 1 | 2022 | 145 | 0.180 |
Why?
|
Sex Factors | 3 | 2024 | 10619 | 0.180 |
Why?
|
Mutation, Missense | 1 | 2010 | 2590 | 0.180 |
Why?
|
Statistics as Topic | 3 | 2016 | 2351 | 0.180 |
Why?
|
Phenylenediamines | 1 | 2021 | 89 | 0.180 |
Why?
|
Beta Rhythm | 2 | 2017 | 65 | 0.180 |
Why?
|
Inflammation | 2 | 2019 | 10860 | 0.180 |
Why?
|
Reproducibility of Results | 5 | 2021 | 20144 | 0.180 |
Why?
|
Schizotypal Personality Disorder | 2 | 2001 | 289 | 0.170 |
Why?
|
Brain Chemistry | 1 | 2003 | 951 | 0.170 |
Why?
|
Blinking | 1 | 2020 | 135 | 0.170 |
Why?
|
Amenorrhea | 1 | 2023 | 470 | 0.170 |
Why?
|
Carbamates | 1 | 2021 | 191 | 0.160 |
Why?
|
Neuronal Plasticity | 1 | 2008 | 1446 | 0.160 |
Why?
|
Amphetamine | 1 | 2020 | 222 | 0.160 |
Why?
|
Interleukin-6 | 2 | 2019 | 3227 | 0.160 |
Why?
|
Psychotherapeutic Processes | 1 | 2019 | 50 | 0.160 |
Why?
|
Smoking Cessation | 3 | 2021 | 2085 | 0.160 |
Why?
|
Microscopy | 1 | 2024 | 902 | 0.160 |
Why?
|
Wounds and Injuries | 2 | 2021 | 2513 | 0.160 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2021 | 451 | 0.160 |
Why?
|
Social Values | 1 | 2019 | 224 | 0.150 |
Why?
|
Tissue Banks | 1 | 2019 | 183 | 0.150 |
Why?
|
Galvanic Skin Response | 2 | 2014 | 359 | 0.150 |
Why?
|
Hunger | 1 | 2020 | 207 | 0.150 |
Why?
|
Dopamine Agents | 1 | 2019 | 186 | 0.150 |
Why?
|
Meditation | 1 | 2001 | 256 | 0.150 |
Why?
|
Germany | 1 | 2020 | 882 | 0.150 |
Why?
|
Contingent Negative Variation | 2 | 2008 | 35 | 0.150 |
Why?
|
Models, Neurological | 2 | 2024 | 1747 | 0.150 |
Why?
|
Electrophysiology | 3 | 2011 | 1263 | 0.150 |
Why?
|
Carbon Radioisotopes | 1 | 2019 | 544 | 0.150 |
Why?
|
Factor Analysis, Statistical | 1 | 2020 | 1001 | 0.150 |
Why?
|
Neurobiology | 1 | 2019 | 135 | 0.150 |
Why?
|
Vagus Nerve | 1 | 2020 | 458 | 0.150 |
Why?
|
Self Report | 5 | 2023 | 3771 | 0.140 |
Why?
|
Primates | 1 | 2019 | 519 | 0.140 |
Why?
|
Behavior Therapy | 1 | 2022 | 886 | 0.140 |
Why?
|
Homozygote | 2 | 2011 | 1775 | 0.140 |
Why?
|
Resilience, Psychological | 1 | 2024 | 808 | 0.130 |
Why?
|
Motor Activity | 2 | 2017 | 2711 | 0.130 |
Why?
|
Tomography, Emission-Computed | 3 | 2004 | 1006 | 0.130 |
Why?
|
Social Stigma | 1 | 2023 | 788 | 0.130 |
Why?
|
Genetic Variation | 1 | 2011 | 6612 | 0.130 |
Why?
|
Discrimination Learning | 2 | 2008 | 276 | 0.130 |
Why?
|
Reference Values | 3 | 2008 | 4913 | 0.130 |
Why?
|
Motor Vehicles | 3 | 2023 | 280 | 0.130 |
Why?
|
Psychotic Disorders | 3 | 2021 | 3276 | 0.120 |
Why?
|
Autonomic Nervous System | 1 | 2020 | 707 | 0.120 |
Why?
|
Imaging, Three-Dimensional | 3 | 2004 | 4047 | 0.120 |
Why?
|
Fibromyalgia | 1 | 2020 | 407 | 0.120 |
Why?
|
Ketamine | 1 | 2021 | 527 | 0.120 |
Why?
|
Mucous Membrane | 1 | 2018 | 658 | 0.120 |
Why?
|
Wakefulness | 1 | 2022 | 1282 | 0.120 |
Why?
|
Remote Consultation | 1 | 2017 | 241 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1791 | 0.120 |
Why?
|
Obsessive-Compulsive Disorder | 2 | 2014 | 1495 | 0.120 |
Why?
|
Language | 2 | 2020 | 1550 | 0.120 |
Why?
|
Immunity, Humoral | 1 | 2019 | 608 | 0.120 |
Why?
|
Residence Characteristics | 1 | 2024 | 2116 | 0.120 |
Why?
|
Photons | 1 | 2018 | 588 | 0.120 |
Why?
|
Glutamine | 1 | 2017 | 575 | 0.120 |
Why?
|
Radiopharmaceuticals | 2 | 2020 | 2704 | 0.110 |
Why?
|
Cocaine | 1 | 2019 | 944 | 0.110 |
Why?
|
Social Perception | 1 | 1998 | 435 | 0.110 |
Why?
|
Uncertainty | 1 | 2019 | 764 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 4 | 2020 | 18075 | 0.110 |
Why?
|
Internet | 2 | 2024 | 3113 | 0.110 |
Why?
|
Medical Records | 1 | 2019 | 1408 | 0.110 |
Why?
|
Peer Group | 1 | 2019 | 702 | 0.110 |
Why?
|
Games, Experimental | 1 | 2013 | 32 | 0.110 |
Why?
|
Electromagnetic Phenomena | 2 | 2008 | 159 | 0.110 |
Why?
|
Parents | 2 | 2020 | 3593 | 0.110 |
Why?
|
Lymphoma | 1 | 2023 | 1900 | 0.110 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2015 | 362 | 0.110 |
Why?
|
Cold Temperature | 1 | 2017 | 794 | 0.110 |
Why?
|
Longitudinal Studies | 7 | 2024 | 14762 | 0.110 |
Why?
|
Behavior, Animal | 1 | 2021 | 1865 | 0.110 |
Why?
|
S-Adenosylmethionine | 1 | 2014 | 219 | 0.100 |
Why?
|
alpha-Methyltyrosine | 1 | 2012 | 6 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2020 | 3359 | 0.100 |
Why?
|
Glucose | 2 | 2004 | 4340 | 0.100 |
Why?
|
Prospective Studies | 5 | 2023 | 54871 | 0.100 |
Why?
|
Saliva | 1 | 2017 | 852 | 0.100 |
Why?
|
Motion Perception | 1 | 2016 | 378 | 0.100 |
Why?
|
Prognosis | 5 | 2021 | 29948 | 0.100 |
Why?
|
Electrocardiography | 1 | 2005 | 6408 | 0.100 |
Why?
|
Trachea | 1 | 2018 | 1094 | 0.100 |
Why?
|
Alpha Rhythm | 2 | 2005 | 107 | 0.100 |
Why?
|
Borderline Personality Disorder | 1 | 2019 | 767 | 0.100 |
Why?
|
Association | 2 | 2001 | 53 | 0.090 |
Why?
|
Influenza Vaccines | 1 | 2019 | 780 | 0.090 |
Why?
|
Low Back Pain | 1 | 2020 | 986 | 0.090 |
Why?
|
Neurogenesis | 1 | 2018 | 862 | 0.090 |
Why?
|
Hormones | 1 | 2015 | 866 | 0.090 |
Why?
|
Autistic Disorder | 1 | 2021 | 1238 | 0.090 |
Why?
|
Cell Communication | 1 | 2018 | 1660 | 0.090 |
Why?
|
Catecholamines | 1 | 2012 | 388 | 0.090 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2014 | 490 | 0.090 |
Why?
|
Visual Perception | 1 | 1999 | 1392 | 0.090 |
Why?
|
Time Factors | 4 | 2018 | 40149 | 0.090 |
Why?
|
Aftercare | 1 | 2017 | 915 | 0.090 |
Why?
|
Interferon-gamma | 1 | 2019 | 3158 | 0.090 |
Why?
|
Radiography | 2 | 2015 | 6968 | 0.090 |
Why?
|
Aged | 9 | 2023 | 171343 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 16044 | 0.090 |
Why?
|
Magnetoencephalography | 2 | 2006 | 585 | 0.090 |
Why?
|
Bulimia Nervosa | 1 | 2012 | 208 | 0.080 |
Why?
|
Internal-External Control | 2 | 2010 | 348 | 0.080 |
Why?
|
Biomarkers, Pharmacological | 1 | 2010 | 161 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2020 | 2171 | 0.080 |
Why?
|
Killer Cells, Natural | 1 | 2019 | 2210 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2021 | 3561 | 0.080 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15416 | 0.080 |
Why?
|
Quinoxalines | 1 | 2011 | 297 | 0.080 |
Why?
|
Benzazepines | 1 | 2011 | 307 | 0.080 |
Why?
|
Heart Rate | 1 | 2020 | 4207 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2010 | 4780 | 0.080 |
Why?
|
Perception | 1 | 2015 | 1204 | 0.080 |
Why?
|
Acute Disease | 2 | 2017 | 7241 | 0.080 |
Why?
|
Comorbidity | 3 | 2019 | 10580 | 0.080 |
Why?
|
Boston | 2 | 2020 | 9346 | 0.080 |
Why?
|
Pilot Projects | 2 | 2021 | 8728 | 0.080 |
Why?
|
Recruitment, Neurophysiological | 1 | 2008 | 35 | 0.080 |
Why?
|
Mental Health | 1 | 2022 | 3270 | 0.070 |
Why?
|
Computer Simulation | 2 | 2020 | 6259 | 0.070 |
Why?
|
Control Groups | 1 | 2008 | 107 | 0.070 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2008 | 113 | 0.070 |
Why?
|
Apoptosis | 1 | 2024 | 9513 | 0.070 |
Why?
|
Visual Fields | 2 | 2008 | 1063 | 0.070 |
Why?
|
Catechol O-Methyltransferase | 1 | 2010 | 250 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2019 | 3853 | 0.070 |
Why?
|
Sensory Thresholds | 1 | 2008 | 377 | 0.070 |
Why?
|
Event-Related Potentials, P300 | 1 | 2008 | 149 | 0.070 |
Why?
|
Antipsychotic Agents | 1 | 2019 | 3078 | 0.060 |
Why?
|
Feasibility Studies | 1 | 2017 | 5306 | 0.060 |
Why?
|
Electromagnetic Fields | 1 | 2008 | 290 | 0.060 |
Why?
|
Electromyography | 2 | 2008 | 1398 | 0.060 |
Why?
|
Personality | 2 | 2019 | 560 | 0.060 |
Why?
|
Limbic System | 1 | 2008 | 418 | 0.060 |
Why?
|
Nervous System | 1 | 2008 | 542 | 0.060 |
Why?
|
Character | 1 | 2005 | 26 | 0.060 |
Why?
|
Emergency Service, Hospital | 2 | 2021 | 7871 | 0.060 |
Why?
|
Linkage Disequilibrium | 1 | 2010 | 1996 | 0.060 |
Why?
|
Algorithms | 3 | 2019 | 14072 | 0.060 |
Why?
|
Logistic Models | 1 | 2019 | 13278 | 0.060 |
Why?
|
Expressed Emotion | 1 | 2005 | 92 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9357 | 0.060 |
Why?
|
Nausea | 1 | 2007 | 681 | 0.060 |
Why?
|
Dizziness | 1 | 2007 | 269 | 0.060 |
Why?
|
Artifacts | 2 | 2004 | 1896 | 0.060 |
Why?
|
Verbal Learning | 1 | 2005 | 459 | 0.050 |
Why?
|
Personality Disorders | 1 | 2007 | 727 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2011 | 2028 | 0.050 |
Why?
|
Radiation, Nonionizing | 1 | 2001 | 5 | 0.050 |
Why?
|
Environment | 1 | 2008 | 1120 | 0.050 |
Why?
|
Buddhism | 1 | 2001 | 23 | 0.050 |
Why?
|
Sodium Chloride | 1 | 2004 | 580 | 0.050 |
Why?
|
Precipitating Factors | 1 | 2021 | 51 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14652 | 0.050 |
Why?
|
Students | 1 | 2011 | 1741 | 0.050 |
Why?
|
Phencyclidine | 1 | 2021 | 59 | 0.050 |
Why?
|
Psychophysiology | 1 | 2021 | 136 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2007 | 3432 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4249 | 0.050 |
Why?
|
Callithrix | 1 | 2021 | 95 | 0.050 |
Why?
|
Temporal Lobe | 1 | 2008 | 1716 | 0.050 |
Why?
|
Chemokine CXCL12 | 1 | 2023 | 457 | 0.040 |
Why?
|
Speech | 1 | 2005 | 555 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39309 | 0.040 |
Why?
|
Neural Inhibition | 1 | 2004 | 589 | 0.040 |
Why?
|
Imagination | 1 | 2001 | 213 | 0.040 |
Why?
|
Verbal Behavior | 1 | 2001 | 328 | 0.040 |
Why?
|
Appetite | 1 | 2022 | 247 | 0.040 |
Why?
|
Judgment | 1 | 2002 | 270 | 0.040 |
Why?
|
Intention | 1 | 2023 | 347 | 0.040 |
Why?
|
Fourier Analysis | 1 | 2000 | 434 | 0.040 |
Why?
|
Trauma Severity Indices | 1 | 2021 | 479 | 0.040 |
Why?
|
Visual Cortex | 2 | 2016 | 1081 | 0.040 |
Why?
|
Religion and Psychology | 1 | 2001 | 180 | 0.040 |
Why?
|
Administration, Oral | 1 | 2007 | 4018 | 0.040 |
Why?
|
Mice, Inbred DBA | 1 | 1999 | 624 | 0.040 |
Why?
|
Visual Pathways | 1 | 2003 | 554 | 0.040 |
Why?
|
Sound Localization | 1 | 1999 | 64 | 0.040 |
Why?
|
Risk Factors | 3 | 2021 | 74881 | 0.040 |
Why?
|
Receptors, CXCR4 | 1 | 2023 | 729 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 10384 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2017 | 26389 | 0.030 |
Why?
|
Disease Progression | 1 | 2014 | 13640 | 0.030 |
Why?
|
Psychological Tests | 1 | 2019 | 642 | 0.030 |
Why?
|
Signal Transduction | 2 | 2023 | 23619 | 0.030 |
Why?
|
United States | 3 | 2021 | 72951 | 0.030 |
Why?
|
Estrogens | 1 | 2023 | 1528 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2015 | 18330 | 0.030 |
Why?
|
Temperament | 1 | 1998 | 300 | 0.030 |
Why?
|
Athletes | 1 | 2023 | 1161 | 0.030 |
Why?
|
Infant | 1 | 2017 | 36461 | 0.030 |
Why?
|
Prevalence | 3 | 2020 | 15835 | 0.030 |
Why?
|
Interferon Type I | 1 | 2019 | 568 | 0.030 |
Why?
|
Lymphocytes | 1 | 2023 | 2605 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2023 | 2474 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2015 | 222 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 42577 | 0.030 |
Why?
|
Cell Survival | 1 | 2024 | 5748 | 0.030 |
Why?
|
Survivors | 1 | 2024 | 2379 | 0.030 |
Why?
|
Energy Metabolism | 2 | 2021 | 2903 | 0.030 |
Why?
|
Mice | 4 | 2024 | 81889 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2019 | 1004 | 0.020 |
Why?
|
Blood Pressure | 1 | 2007 | 8533 | 0.020 |
Why?
|
Cohort Studies | 1 | 2014 | 41710 | 0.020 |
Why?
|
Image Enhancement | 1 | 2021 | 2857 | 0.020 |
Why?
|
Cell Movement | 1 | 2023 | 5199 | 0.020 |
Why?
|
Age Factors | 1 | 2007 | 18397 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2019 | 22352 | 0.020 |
Why?
|
Stroop Test | 1 | 2010 | 72 | 0.020 |
Why?
|
Prolactin | 1 | 2012 | 627 | 0.020 |
Why?
|
Blood Glucose | 1 | 2004 | 6422 | 0.020 |
Why?
|
Social Adjustment | 1 | 2011 | 634 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2808 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2019 | 3468 | 0.020 |
Why?
|
Random Allocation | 2 | 2001 | 2394 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2010 | 949 | 0.020 |
Why?
|
Behavior, Addictive | 1 | 2012 | 429 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5098 | 0.020 |
Why?
|
Benzamides | 1 | 2011 | 1375 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2007 | 712 | 0.020 |
Why?
|
Macrophages | 1 | 2019 | 5783 | 0.010 |
Why?
|
Fluoxetine | 1 | 2007 | 732 | 0.010 |
Why?
|
Psychotherapy | 1 | 2012 | 1648 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2019 | 14471 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18984 | 0.010 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2007 | 627 | 0.010 |
Why?
|
Word Association Tests | 1 | 2001 | 49 | 0.010 |
Why?
|
Psychological Theory | 1 | 2001 | 172 | 0.010 |
Why?
|
England | 1 | 2001 | 533 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24295 | 0.010 |
Why?
|
Delusions | 1 | 2001 | 300 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 30237 | 0.010 |
Why?
|
Reading | 1 | 2001 | 540 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2014 | 4421 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2007 | 2779 | 0.010 |
Why?
|
Linear Models | 1 | 2006 | 5874 | 0.010 |
Why?
|
Health Status | 1 | 2007 | 4087 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2007 | 81635 | 0.000 |
Why?
|